Abstract:Background Salt‐sensitive hypertension is highly prevalent and associated with cardiorenal damage. Large clinical trials have demonstrated that SGLT2 (sodium‐glucose cotransporter 2) inhibitors exert hypotensive effect and cardiorenal protective benefits in patients with hypertension with and without diabetes. However, the underlying mechanism remains elusive. Methods and Results Dahl salt‐sensitive rats and salt‐insensitive controls were fed with 8% high‐salt diet and some of them were treated with canagliflozin. The blood pressure, urinary sodium excretion, and vascular function were detected. Transient receptor potential channel 3 (TRPC3) knockout mice were used to explain the mechanism. Canagliflozin treatment significantly reduced high‐salt‐induced hypertension and this effect was not totally dependent on urinary sodium excretion in salt‐sensitive hypertensive rats. Assay of vascular function and proteomics showed that canagliflozin significantly inhibited vascular cytoplasmic calcium increase and vasoconstriction in response to high‐salt diet. High salt intake increased vascular expression of TRPC3 in salt‐sensitive rats, which could be alleviated by canagliflozin treatment. Overexpression of TRPC3 mimicked salt‐induced vascular cytosolic calcium increase in vitro and knockout of TRPC3 erased the antihypertensive effect of canagliflozin. Mechanistically, high‐salt‐induced activation of NCX1 (sodium‐calcium exchanger 1) reverse mode increased cytoplasmic calcium level and vasoconstriction, which required TRPC3, and this process could be blocked by canagliflozin. Conclusions We define a previously unrecognized role of TRPC3/NCX1 mediated vascular calcium dysfunction in the development of high‐salt‐induced hypertension, which can be improved by canagliflozin treatment. This pathway is potentially a novel therapeutic target to antagonize salt‐sensitive hypertension. Nonstandard Abbreviations and Acronyms [Ca 2+ ]cyt cytosolic free calcium concentration NCX1 sodium‐calcium exchanger 1 ND normal diet SGLT2i sodium‐glucose exchanger 2 inhibitor SS Dahl salt‐sensitive rats SS‐19BN Dahl salt‐insensitive rats TRPC3 transient receptor potential channels 3 Clinical Perspective What Is New? The SGLT2 (sodium‐glucose cotransporter 2) inhibitor canagliflozin antagonizes salt‐induced hypertension in salt‐sensitive rats by directly alleviating vasoconstriction. Salt‐induced vascular transient receptor potential channel 3 upregulation results in an augmented vasoconstriction in salt‐sensitive hypertensive rats through facilitating NCX1 (sodium‐calcium exchanger 1)‐mediated vascular calcium uptake, which could be alleviated by canagliflozin. What Are the Clinical Implications? Antagonizing the interaction between transient receptor potential channel 3 and NCX1 by the SGLT2 inhibitor canagliflozin would represent a novel target to antagonize salt‐sensitive hypertension. Canagliflozin exerts its antihypertensive effect beyond its canonical effect on renal natriuresis. Cardiovascular disease has always been the biggest threat to human health. 1 Chronic vascular diseases such as hypertension and atherosclerosis are the main pathogenic factors or early pathological processes of high‐mortality diseases such as coronary heart disease, myocardial infarction, and heart failure. High salt intake not only acts as an independent risk factor for hypertension but also causes cardiovascular and renal damage. 2 , 3 High salt intake raises blood pressure (BP) through activation of the sympathetic nerve system and renin‐angiotensin system and leads to renal sodium retention. 4 Modest reduction in dietary salt intake substantially reduces cardiovascular events in the general population, but daily salt intake has remained unchanged in the past 2 decades. 5 , 6 Thus, to identify an alternative therapy for reducing t -Abstract Truncated-

Calcitriol ameliorates renal injury with high-salt diet-induced hypertension by upregulating GLIS2 expression and AMPK/mTOR-regulated autophagy

Calcitriol ameliorates damage in high-salt diet-induced hypertension: Evidence of communication with the gut–kidney axis

The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-Induced Diabetic Rats

Calcitriol reverses age-related hypertension via downregulating renal AP1/AT1R pathway through regulating mitochondrial function

S-18-3: SGLT2 INHIBITOR CANAGLIFLOZIN ANTAGONIZES SALT-SENSITIVE HYPERTENSION THROUGH MODIFYING TRPC3 MEDIATED VASCULAR CALCIUM HANDLING

Telmisartan down-regulates the serum calcineurin expression in amelioration the left ventricular remodeling in rats with 2-kidney, 1-clip hypertension

Calcitriol ameliorates the progression of hepatic fibrosis through autophagy-related gene 16-like 1-mediated autophagy

Calcitriol combined with high‐calcium and high‐phosphorus diet induces vascular calcification model in chronic kidney disease rats

Influence of Telmisartan on peripheral calcineurin of rat with two kidneys one clip hypertension

Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca 2+ -ATPase activity in rat cardiac pressure-overload hypertrophy

Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.

Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists

Calcineurin Inhibitor Attenuates the Development and Induces the Regression of Cardiac Hypertrophy in Rats with Salt-Sensitive Hypertension.

Recombinant Cellular Repressor of E1A-Stimulated Genes Protects Against Renal Fibrosis in Dahl Salt-Sensitive Rats

VEGFC ameliorates salt-sensitive hypertension and hypertensive nephropathy by inhibiting NLRP3 inflammasome via activating VEGFR3-AMPK dependent autophagy pathway

Identification of crucial genes and possible molecular pathways associated with active vitamin D intervention in diabetic kidney disease

Olmesartan Attenuates Cardiac Hypertrophy and Improves Cardiac Diastolic Function in Spontaneously Hypertensive Rats Through Inhibition of Calcineurin Pathway.

Hyperoside Ameliorates Renal Tubular Oxidative Damage and Calcium Oxalate Deposition in Rats through AMPK/Nrf2 Signaling Axis

Calcitriol inhibits apoptosis via activation of autophagy in hyperosmotic stress stimulated corneal epithelial cells in vivo and in vitro

Up-Regulation of Intrarenal Renin- Agiotensin System Contributes to Renal Damage in High-Salt Induced Hypertension Rats

Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression